Education
About Us
Working with TipRanks
Follow Us
Ypsomed Holding AG (GB:0QLQ)
:0QLQ
RESEARCH TOOLSreports
0QLQ Stock Chart & Stats
Day’s Range― - ―
52-Week RangeCHF279.50 - CHF438.50
Previous CloseN/A
Volume11.46K
Average Volume (3M)1.03K
Market Cap
CHF5.51B
Enterprise ValueCHF2.71B
Total Cash (Recent Filing)CHF52.31M
Total Debt (Recent Filing)CHF325.19M
Price to Earnings (P/E)63.1
Beta0.75
Next Earnings
Nov 12, 2025EPS EstimateN/A
Next Dividend Ex-Date
Jul 04, 2025Dividend Yield0.48%
Share Statistics
EPS (TTM)4.02
Shares Outstanding13,649,739
10 Day Avg. Volume2,137
30 Day Avg. Volume1,033
Financial Highlights & Ratios
PEG Ratio0.46
Price to Book (P/B)4.59
Price to Sales (P/S)0.00
P/FCF Ratio-65.13
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
CHF430.33Price Target Upside6.39% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering3
Ypsomed Holding AG News
Options Prices
Currently, No data available
---
Ownership Overview
―
Insiders
2.91%
Mutual Funds
― Other Institutional Investors
95.72% Public Companies and
Individual Investors
0QLQ FAQ
What was Ypsomed Holding AG’s price range in the past 12 months?
Ypsomed Holding AG lowest share price was CHF279.50 and its highest was CHF438.50 in the past 12 months.
What is Ypsomed Holding AG’s market cap?
Ypsomed Holding AG’s market cap is CHF5.51B.
When is Ypsomed Holding AG’s upcoming earnings report date?
Ypsomed Holding AG’s upcoming earnings report date is Nov 12, 2025 which is in 142 days.
How were Ypsomed Holding AG’s earnings last quarter?
Ypsomed Holding AG released its earnings results on May 21, 2025. The company reported CHF4.023 earnings per share for the quarter, beating the consensus estimate of N/A by CHF4.023.
Is Ypsomed Holding AG overvalued?
According to Wall Street analysts Ypsomed Holding AG’s price is currently Undervalued.
Does Ypsomed Holding AG pay dividends?
Ypsomed Holding AG pays a Annually dividend of CHF2.2 which represents an annual dividend yield of 0.48%. See more information on Ypsomed Holding AG dividends here
What is Ypsomed Holding AG’s EPS estimate?
Ypsomed Holding AG’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Ypsomed Holding AG have?
Ypsomed Holding AG has 13,649,739 shares outstanding.
What happened to Ypsomed Holding AG’s price movement after its last earnings report?
Ypsomed Holding AG reported an EPS of CHF4.023 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went up 1.404%.
Which hedge fund is a major shareholder of Ypsomed Holding AG?
Currently, no hedge funds are holding shares in GB:0QLQ
Company Description
Ypsomed Holding AG
Ypsomed Holding AG, together with its subsidiaries, develops, manufactures, and sells injection and infusion systems for pharmaceutical and biotechnology companies. The company operates in two segments, Ypsomed Delivery Systems and Ypsomed Diabetes Care. The Ypsomed Delivery Systems segment provides various injection systems, such as pen injectors, auto injectors, patch injectors, and wearable injectors, as well as other smart devices. This segment offers its products under the YDS brand. The Ypsomed Diabetes Care segment sells and trades in insulin pumps, infusion sets, pen needles, blood glucose monitoring systems, accessories, and other day-to-day items for diabetics. This segment offers its products under the mylife brand name. The company offers precision turned parts; and contract manufacturing and other services. It markets its products through biotechnology and pharmaceutical partners, as well as through its own distribution network and independent distributors. It operates in Switzerland, Europe, North America, and internationally. Ypsomed Holding AG was founded in 1984 and is headquartered in Burgdorf, Switzerland.
0QLQ Stock 12 Month Forecast
Average Price Target
CHF430.33
▲(6.39%Upside)